Iminosugar-Based Antitumoural Agents

Iminosugars: From Synthesis to Therapeutic Applications

Volumn , Issue , 2008, Pages 269-294

  Nishimura, Yoshio ^a  

^a INSTITUTE OF MICROBIAL CHEMISTRY   (Japan)

Author keywords

Complex type asparagine linked oligosaccharides; D galacturonic acid type iminosugars; Enzymatic glycosidic hydrolysis; Glycoconjugates cell surface carbohydrates; Heparan sulphate proteoglycans; Hexose mimetic iminosugars; Hexuronic acid mimicking iminosugars; L iduronic acid related iminosugars; Mannosyl oxocarbenium ion; Tumour cell surface oligosaccharides

Indexed keywords

EID: 84878838683     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470517437.ch12     Document Type: Chapter

References (114)

1. Warren, L., Buck, C. A., and Tuszynski, G. P (1978) Glycopeptide changes and malignant transformation: a possible role for carbohydrate in malignant behavior. Biochim. Biophys. Acta., 516, 97-127.
2. Hakomori, S-I (1989) Aberrant glycosylation in tumors and tumorassociated carbohydrate antigens. Adv. Cancer Res., 52, 257-331.
3. Dennis, J. W. (1991) Changes in glycosylation with malignant transformation and tumor progression, in Cell Surface Carbohydrates and Cell Development, (ed. Fukuda, M.), CRC Press, Boca Raton, USA, pp. 161-194.
4. Varki, A. (1993) Biological roles of oligosaccharides: all of the theories are correct. Glycobiology, 3, 97-130.
5. Muramatsu, T. (1993) Carbohydrate signals in metastasis and prognosis of human carcinomas. Glycobiology, 3, 294-296.
6. Kornfeld, R. and Kornfeld, S. (1985) Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem., 54, 631-664.
7. Elbein, A. D. and Molyneux, R. J. (1999) Inhibitors of glycoprotein processing, in Iminosugars as Glycosidase Inhibitors (Stütz, A., ed.), Wiley-VCH, Weinheim, Germany, pp. 216-251.
8. Kjellen, L. and Lindahl, U. (1991) Proteoglycans: structures and interactions. Annu. Rev. Biochem., 60, 443-475.
9. Vlodavsky, I., Bar-Shavit, R., Korner, G. and Fucks, Z. (1993) Extracellular matrix-bound growth factors, enzymes and plasma proteins, in Basement Membranes: Cellular and Molecular Aspects (Rohrbach, D. H. and Timpl, R., eds), Academic Press, Orland, USA, pp. 327-343.
10. Iozzo, R. V. (1998) Matrix proteoglycans: from molecular design to cellular function. Annu. Rev. Biochem., 67, 609-652.
11. Turnbull, J., Powell, A. and Guimond, S. (2001) Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol., 11, 75-82.
12. Esko, J. D. and Selleck, S. B. (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem., 71, 435-471.
13. Liotta, L. A., Thorgeirsson, U. P. and Garbisa, S. (1982) Role of collagenase in tumor cell invasion. Cancer Metastasis Rev., 1, 277-288.
14. Sloane, B. F. and Honn, K. V. (1984) Cysteine proteinase and metastasis. Cancer Metastasis Rev., 3, 249-263.
15. Woolley, D. E. (1984) Collagenolytic mechanisms in tumor cell invasion. Cancer Metastasis Rev., 3, 361-372.
16. Bernacki, R., Niedbala, M. J. and Korytnyk, W. (1985) Glycosidases in cancer and invasion. Cancer Metastasis Rev., 4, 81-101.
17. Nakajima, M. Irimura, T. and Nicolson, G. L. (1988) Heparanase and tumor metastasis. J. Cell Biochem., 36, 157-167.
18. Nakajima, M. Morikawa, K, Fabra, A., Bucana, C. D. and Fidler, I. J. (1990) Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J. Natl. Cancer Inst., 82, 1890-1898.
19. Wrodnigg, T. M., Steiner, A. J. and Ueberbacher, B. J. (2007) Natural and synthetic iminosugars as carbohydrate-processing enzyme inhibitors for cancer therapy. Curr. Med. Chem. Anti-cancer Agents. In press.
20. Elbein, A. D. (1991) Glycosidase inhibitors: inhibitors of N-linked oligosaccharide processing. FASEB J., 5, 3055-3063.
21. Nishimura, Y. (1992) Glycosidase and glycosyltransferase inhibitors, in Studies in Natural Products Chemistry, Volume 10, (Atta-ur-Rahman, ed.), Elsevier, Amsterdam, Holland, pp. 495-583.
22. Winchester, B. and Fleet, G. W. J. (1992) Amino-sugar glycosidase inhibitors: versatile tools for glycobiologists. Glycobiology, 2, 199-210.
23. Asano, N. (2003) Natural occurring iminosugars and related compounds: structure, distribution, and biological activity. Curr. Top. Med. Chem., 3, 471-484.
24. Yagishita, K., Ohkura, T., Tachibana, Y., Takasuki, S. and Kobata, A. (1984) Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis. J. Biol. Chem., 259, 10834-10840.
25. Collard, J. G., Van Beek, W. P., Jansen, J. W. G. and Schijiven, J. F. (1985) Transfection by human oncogenes: concomitant induction of tumorigenicity and tumor-associated membrane alterations. Int. J. Cancer, 35, 207-214.
26. Pierce, M. and Arngo, J. (1986) Rous sarcoma virus-transformed baby hamster kidney cells express higher levels of asparagine-linked tri-and tetraantennary glycopeptides containing [GLcNac-α(1,6)Man-β-(1,6)Man] and poly-Nacetyllactosamine sequences than baby hamster kidney cells. J. Biol. Chem., 261, 10772-10777.
27. Debray, H., Qin, Z., Delannoy, P., Montreuil, J., Dus, D., Radikowski, C., Christensen, B. and Kieler, J. (1986) Altered glycosylation of membrane glycoproteins in human uroepithelial cell lines. Int. J. Cancer, 37, 607-611.
28. Kerbel, R. S., Waghorne, C. Man, M. S., Elliott, B. and Breitman, M. L. (1987) Alteration of tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection. Proc. Natl. Acad. Sci. USA, 84, 1263-1267.
29. Dennis, J. W. and Laferté, S. (1988) Asn-linked oligosaccharides and metastatic phenotype, in Altered Glycosylation in Tumor Cells, (eds Reading, C. L., Hakomori, S. and Marcus, D. M.), Alan R. Liss, New York, USA, pp. 257-267.
30. Hettkamp, H., Bause, E. and Legler, G. (1982) Inhibition by nojirimycin and 1-deoxynojirimycin of microsomal glucosidases from calf liver acting on the glycoprotein oligosaccharides Glc1-3Man9GlcNAc2. Biosci. Rep., 2, 899-906.
31. Bischoff, J. and Kornfeld, R. (1984). The effect of 1-deoxymannojirimycin on rat liver β-mannosidases. Biochem. Biophys. Res. Commun., 125, 324-331.
32. Fechter, M. H., Stütz, A. E. and Tauss, A. (1999) Chemical and chemo-enzymatic approaches to unnatural ketoses and glycosidase inhibitors with basic nitrogen in the sugar ring. Curr. Org. Chem., 3, 269-285.
33. Cipolla, L., La Ferla, B. and Nicotra, F. (2003) General methods for iminosugar synthesis. Curr. Top. Med. Chem., 3, 485-511.
34. Tsuruoka, T., Fukuyasu, H., Ishii, M., Usui, T., Shibahara, S. and Inouye, S. (1996) Inhibition of mouse tumor metastasis with nojirimycin-related compounds. J. Antibiot., 49, 155-161.
35. Tsukamoto, K., Uno, A., Kubota, Y., Shimada, S., Hori, Y. and Imokawa, G. (1992) Role of asparagine-linked carbohydrates in pulmonary metastasis of B16-F10 murine melanoma cells: implication through glycosylation inhibition by nojirimycin. Melamona Res., 2, 33-39.
36. Molyneux, R. J. and James, L. F. (1991) Swaisonine, slaframine and castanospermine, in Mycotoxins Phytoalexins, CRC Press, Boca Raton, USA, pp. 637-656.
37. Elbein, A. D., Solf, R., Dorling, P. R. and Vosbeck, K. (1981) Swainsonine: an inhibitor of glycoprotein processing. Proc. Natl. Acad. Sci.,78, 7393-7397.
38. Tulsiani, D. R. P., Harris, T. M. and Touster, O. (1982) Swainsonine inhibits the biosynthesis of complex glycoproteins by inhibition of Golgi mannosidase II. J. Biol. Chem., 257, 7936-7939.
39. Tulsiani, D. R. P. and Touster, O. (1983) Swainsonine causes the production of hybrid glycoproteins by human skin fibroblasts and rat liver Golgi preparation. J. Biol. Chem., 258, 7578-7585.
40. Winchester, B., Al Daher, S., Carpenter, N. C., Cenci di Bello, I., Choi, S. S., Fairbanks, A. J. and Fleet, G. W. J. (1993) The structural basis of the inhibition of human β-mannosidases by azafuranose analogs of mannose. Biochem. J., 290, 743-749.
41. Sasak, V. W., Ordovas, J. M., Elbein, A. D. and Berninger, R. W. (1985) Castanospermine inhibits glucosidase I and glycoprotein secretion in human hepatoma cells. Biochem. J., 232, 759-766.
42. Palamarczyk, G. and Elbein, A. D. (1985) The effect of castanospermine on the oligosaccharide structures of glycoproteins from lymphoma cell lines. Biochem. J., 227, 795-804.
43. Merkle, R. K., Elbein, A. D. and Heifetz, A. J. (1985) The effect of swainsonine and castanospermine on the sulfation of the oligosaccharide chains of N-linked glycoproteins. J. Biol. Chem., 260, 1083-1089.
44. Gross, V., Train-Thi, T-A., Schwarz, R. T., Elbein, A. D., Decker, K. and Heinrich, P. C. (1986) Different effects of the glucosidase inhibitors 1-deoxynojirimycin, N-methyl-1-deoxynojirimycin and castanospermine on the glycosylation of rat β1-proteinase inhibitor and β1-acid glycoprotein. Biochem. J., 236, 853-860.
45. Foddy, L. and Hughes, C. (1988) Assembly of asparagine-linked oligosaccharides in baby hamster kidney cells treated with castanospremine, an inhibitor of processing glucosidases. Eur. J. Biochem., 175, 291-299.
46. Nemr, A. E. (2000) Synthetic methods for the stereoisomers of swainsonine and its analogues. Tetrahedron, 56, 8579-8629.
47. Zhao, H., Hans, S., Cheng, X. and Mootoo, D. R. (2001) Allylated monosaccharides as precursors in triple reduction amination strategies: synthesis of castanospermine and swainsonine. J. Org. Chem., 66, 1761-1767.
48. Pyne, S. G. (2005) Recent developments on the synthesis of (-)-swainsonine and analogues. Curr. Org. Synth., 2, 39-57.
49. Martin, R., Murruzzu, C., Pericas, M. A. and Riera, A. (2005) General approach to glycosidase inhibitors. Enantioselective synthesis of deoxymannojirimycin and swainsonine. J. Org. Chem., 70, 2325-2328.
50. Michael, J. P. (2005) Indolizidine and quinolizidine alkaloids. Nat. Prod. Rep., 21, 625-649.
51. Humphries, M. J., Matsumoto, K., White, S. L. and Olden, K. (1986) Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors. Cancer Res., 46, 5215-5222.
52. Dennis, J. W. (1986) Effect of swainsonine and polyinosinic: polycytidylic acid on murine tumor cell growth and metastasis. Cancer Res., 46, 5131-5136.
53. Humphries, M. J., Matsumoto, K., White, S. L., Molyneux, R. J. and Olden, K. (1990) An assessment of the effects of swainsonine on survival of mice injected with B16-F10 melanoma cells. Cin. Exp. Metastasis, 8, 89-102.
54. Kino, T., Inamura, N., Nakahara, K., Kiyota, S., Goto, T., Terano, H., Kohsaka, M., Aoki, H. and Imanaka, H. (1985) Studies of immunomodulator, swainsonine II. Effect of swainsonine on mouse immunodeficient system and experimental murine tumor. J. Antibiot., 38, 936-940.
55. Humphries, M. J., Matsumoto, K., White, S. L., Molyneux, R. J. and Olden, K. (1988) Augmentation of murine natural killer cell activity by swaisonine, a new antimetastatic immunomodulator. Cancer Res., 48, 1410-1415.
56. Olden, K., Breton, P., Grzegorzewski, K. Yasuda, Y. Gause, B. L., Oredipe, O. A., Newton, S. A. and White, S. L. (1991) The potential importance of swainsonine in therapy for cancers and immunology. Pharm. Ther., 50, 285-290.
57. Hino, M., Nakayama, O., Tsurumi, Y., Adachi, K., Shibata, T., Terano, H., Kohsaka, M., Aoki, H. and Imanaka, H. (1985) Studies of an immunomodulator, swainsonine I. Enhancement of immune response by swainsonine in vitro. J. Antibiot., 38, 926-935.
58. Humphries, M. J., Matsumoto, K., White, S. L. and Olden, K. (1986) Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells. Proc. Natl. Acad. Sci., USA, 83, 1752-1756.
59. Dennis, J. W., Koch, K., Yousefi, S. and VanderElst, I. (1990) Growth inhibition of human melanoma tumor xenografts in athymic nude mice by swainsonine. Cancer Res., 50, 1867-1872.
60. Olden, K., Breton, P. Grzegorzewski, K., Yasuda, Y., Gause, B. L., Oredipe, O. A., Newton, S. A. and White, S. L. (1991) The potential importance of swainsonine in therapy for cancers and immunology. Pharm. Ther., 50, 285-290.
61. Goss, P. E., Baptiste, J., Fernandes, B., Baker, M. and Dennis, J. W. (1994) A phase study of swaisonine in patients with advanced malignancies. Cancer Res., 54, 1450-1457.
62. Baptista, J. A., Goss, P., Nghiem, M., Krepinsky, J. J., Baler, M. and Dennis, J. W. (1994) Measuring swainsonine in serum of cancer patients: Phase I clinical trial. Clin. Chem., 40, 426-430.
63. Goss, P. E., Baker, M. A., Carver, J. P. and Dennis, J. W. (1995) Inhibition of carbohydrate processing: a new class of anticancer agents. Clin. Cancer Res., 1, 935-944.
64. Goss, P. E., Reid, C. L., Bailey, D. and Dennis, J. W. (1997) Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies. Clin. Cancer Res., 3, 1077-1086.
65. Shaheen, P. E., Stadler, W., Elson, P. Knox, J. Winquist, E. and Bukowski, R. M. (2005) Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or matastatic renal cell carcinoma. Invest. New Drug, 23, 577-581.
66. Pili, R., Chang, J., Partis, R. A., Mueller, R. A., Chrest, F. J. and Passaniti, A. (1995) The β-glucosidase I inhibitor castanospermine alert endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth. Cancer Res., 55, 2920-2926.
67. Ostrander, G. K., Scribner, N. K. and Rohrschneider L. R. (1988) Inhibition of v-fms-induced tumor growth in nude mice by castanospermine. Cancer Res., 48, 1091-1094.
68. Spearman, M. A., Ballon, B. C., Gerrard, J. M., Greenberg, A. H. and Wright, J. A. (1991) The inhibition of platelet aggregation of metastatic H-ras-transformed 10T1/2 fibroblasts with castanospermine, an N-linked glycoprotein processing inhibitor. Cancer Lett., 60, 185-191.
69. Tsuruoka, T., Niwa, T., Shomura, T., Matsuno, T., Itoh, N., Inouye, S. and Niida, T. (1973) Synthesis of d-glucaro--lactam, an oxidation product of nojirimycin. Sci. Rep. Meiji Seika Kaisha, 13, 80-84.
70. Umezawa, H., Aoyagi, T., Komiyama, H., Morishima, M., Hamada, M. and Takeuchi, T. (1974) Purification and characterization of a sialidase inhibitor, siastatin produced by Streptomyces. J. Antibiot., 27, 963-969.
71. Manning, K. S., Lynn, D. G., Shabanowitz, J., Fellows, L. E., Singh, M. and Schrire, B. D. J. (1985) A glucuronidase inhibitor from the seeds of Baphia racemosa: application of fast atom bombardment coupled with collision activated dissociation in natural product structure assignment. Chem. Commun., 127-129.
72. Nishimura, Y. (1995) Stereoselective synthesis and transformation of siastatin B, a novel glycosidase inhibitor, directed toward new drugs for viral infection and tumor metastasis, in Studies in Natural Products Chemistry, Volume 16 (Atta-ur-Rahman, ed.), Elsevier, Amsterdam, Holland, pp. 75-121.
73. Takatsu, T., Takahashi, M., Kawase, Y., Enokita, R., Okazaki, T., Matsukawa, H., Ogawa, K., Sakaida, Y., Kagasaki, T., Kinoshita, T., Nakajima, M. and Tanzawa, K. (1996) A-72363 A-1, A-2, and C, novel heparanase inhibitors from Streptomyces nobilis SANK 60192, I. Taxonomy of producing organism, fermentation, isolation and structural elucidation. J. Antibiot., 49, 54-60.
74. Kawase, Y., Takahashi, M., Takatsu, T., Arai, M., Nakajima, M. and Tanzawa, K. (1996) A-72363 A-1, A-2, and C, novel heparanase inhibitors from Streptomyces nobilis SANK 60192, II. Biological activities. J. Antibiot., 49, 61-64.
75. Kim, Y. J., Ichikawa, M. and Ichikawa, Y. J. (2000) Highly selective synthesis of 1-N-iminosugars of the d-glucose and-glucuronic acid types. J. Org. Chem., 65, 2599-2602.
76. Nishimura, Y. (2006) gem-Diamine 1-N-iminosugars, a new family of glycosidase inhibitors: synthesis and biological activity. Heterocycles, 67, 461-488.
77. Yu, W-H. and Woessner, J. F. Jr. (2000) Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J. Biol. Chem., 275, 4183-4191.
78. Nakajima, M. Irimura, T., Di Ferrante, N. and Nicolson, G. L. (1984) Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. J. Biol. Chem., 259, 2283-2290.
79. Toyoshima, M. and Nakajima, M. (1999) Human heparanase. Purification, characterization, cloning, and expression. J. Biol. Chem., 274, 24153-24160.
80. Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I. and Speckers, I. (1999) Mammalian heparanase: gene cloning, expression, and fuction in tumor progression and matastasis. Nat. Med., 5, 793-802.
81. Hulett, M. D., Freeman, B. J., Baker, R. T., Harris, M. J. and Parish, C. R. (1999) Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat. Med., 5, 803-809.
82. Fairbanks, M. B., Mildner, A. M., Leone, J. W., Cavey, G. S., Mathews, W. R., Drong, R. F., Slightom, J. L., Bienkowski, M. J., Smith, C. W., Bannow, C. A. and Heinrikson, R. L. (1999) Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer. J. Biol. Chem., 274, 29587-29590.
83. Kussie, P. H., Hulmers, J. D., Ludwig, D. L., Patel, S., Navarro, E. C., Seddon, A. P., Giorgio, N. A. and Bohlen, P. (1999) Cloning and functional expression of a human heparanase gene. Biochem. Biophys. Res. Commun., 261, 183-187.
84. Vlodavsky, I., Goldshmidt, O., Zcharia, E., Metzger, S., Chajek-Shaul, T., Atzmon, R., Guatta-Rangini, Z. and Friedmann, Y. (2001) Molecular properties and involvement of heparanase in cancer progression and normal development. Biochimie, 83, 831-839.
85. Goldshmidt, O., Zcharia, E., Abramovitch, R., Metzger, S., Aingorn, H., Friedmann, Y., Schirrmacher, V., Mitrani, E. and Vlodavsky, I. (2002) Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis. Proc. Natl. Acad.Sci. USA, 99, 10031-10036.
86. Vlodavsky, I. and Friedmann, Y. (2001) Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J. Clin. Invest., 108, 341-347.
87. Capila, I. and Linhardt, R. J. (2002) Heparin-protein interactions. Angew. Chem. Int. Ed., 41, 391-412.
88. Chapman, E., Michael, D. B., Sarah, R. H. and Wong, C-H. (2004) Sulfotransferase: structure, mechanism, biological activity, inhibition, and synthetic utility. Angew. Chem. Int. Ed., 43, 3526-3548.
89. Fuster, M. and Esko, J. D. (2005) The sweet and sour of cancer: glycans as novel therapeutic targets. Nat. Rev. Cancer, 5, 526-542.
90. Fjeldstad, K. and Kolset, S. O. (2005) Decreasing the metastatic potential in cancers-targeting the heparan sulfate proteoglycans. Curr. Drug Targets, 6, 665-682.
91. Nishimura, Y. (2003) gem-Diamine 1-N-iminosugars and related iminosugars, candidate of therapeutic agents for tumor metastasis. Curr. Top. Med. Chem., 3, 575-591.
92. Kudo, T., Nishimura, Y. Kondo, S. and Takeuchi, T. (1992) Totally synthetic analogues of siastatin. I. Optical active 2-acetamidopiperidine derivatives. J. Antibiot., 45, 954-962.
93. Nishimura, Y. Kudo, T. Kondo, S. and Takeuchi, T. (1992) Totally synthetic analogues of siastatin B. II. Optically active piperidine derivative having trifluoroacetamide and hydroxyacetamide groups at C-2'. J. Antibiot., 45, 963-970.
94. Satoh, T., Nishimura, Y. Kondo, S. and Takeuchi, T. (1996) A practical synthesis from siastatin B of (3S,4S,5R,6R)-4,5-dihydroxy-6-(trifluoroacetamido)piperidine-3-carboxylic acid having antimetastatic activity in mice. Carbohydr. Res., 286, 173-178.
95. Satoh, T., Nishimura, Y., Kondo, S. and Takeuchi, T. (1996) Synthesis and antimetastatic activity of 6-trichlorocetamido and 6-guanidino analogues of siastatin B. J. Antibiot., 49, 321-325.
96. Nishimura, Y., Satoh, T., Adachi, H, Kondo, S., Takeuchi, T, Azetaka, M., Fukuyasu, H. and Iizuka, Y. (1996) The first l-iduronic acid-type 1-N-iminosugars having inhibitory activity of experimental metastasis. J. Am. Chem. Soc., 118, 3051-3052.
97. Nishimura, Y., Satoh, T. Adachi, H., Kondo, S., Takeuchi, T. Azetaka, M., Fukuyasu, H. and Iizuka, Y. (1997) Synthesis and antimetastatic activity of l-iduronic acid-type 1-N-iminosugars. J. Med. Chem., 40, 2626-2633.
98. Nishimura, Y. Shitara, E., Adachi, H., Toyoshima, M., Nakajima, M., Okami, Y. and Takeuchi, T. (2000) Flexible synthesis and biological activity of uronic acid-type gem-diamine 1-N-iminosugars: a new family of glycosidase inhibitors. J. Org. Chem., 65, 2-11.
99. Yogeeswaran, G. and Salk, P. (1981) Metastatic potential is positively correlated with cell surface sialylation of cultured murine cell lines. Science (Wash. DC), 212, 1514-1516.
100. Fogel, M., Altevogt, P. and Schirrmacher, V. (1983) Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation. J. Exp. Med., 157, 371-376.
101. Peracaula, R. Tabares, G. Lopez-Ferrer, A. Brossmer, R., de Bolos, C. and de Llorens, R. (2005) Role of sialyltransferases involved in the biosynthesis of Lewis antigens in human pancreatic tumor cells. Glycoconjugate J., 22, 135-144.
102. Cheung I. Y., Vickers, A. and Cheung, N. K. (2006) Sialyltransferase STX (ST8SiaII): a novel molecular marker of metastatic neuroblastoma. Int. J. Cancer, 119, 152-156.
103. Kijima-Suda, I., Miyamoto, Y., Toyoshima, S., Itoh, M. and Osawa, T. (1986) Inhibition of experimental pulmonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid: nucleoside conjugate having sialyltransferase inhibiting activity. Cancer Res., 46, 858-862.
104. Kijima-Suda, I. Miyazawa, T., Itoh, M., Toyoshima, S. and Osawa, T. (1988) Possible mechanism of inhibition of experimental pulmonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid: nucleoside conjugate. Cancer Res., 48, 3728-3732.
105. Brown, J. M., Nishimura, Y. and Esko, J. D. (2006) Synthesis and biological evaluation of gem-diamine 1-N-iminosugars related to l-iduronic acid as inhibitors of heparan sulfate 2-O-sulfotransferase. Bioorg. Med. Chem. Lett., 16, 532-536.
106. Rapraeger, A. C. (1995) In the clutches of proteoglycans: how does heparin sulfate regulate FGF binding? Chem. Biol., 2, 645-649.
107. Faham, S., Hileman, R.E., Fromm, J. R., Linhardt, R. J. and Rees, D. C. (1996) Heparin structure and interactions with basic fibroblast growth factor. Science, 271, 1116-1120.
108. Pye, D. A., Vives, R. R., Turnbull, J. E., Hyde, P. and Gallagher, J. T. (1998) Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity. J. Biol. Chem., 273, 22936-22942.
109. Zhang, L. J., Beeler, D. L., Lawrence, R., Lech, M., Liu, J., Davis, J. C., Shriver, Z., Sasisekharan, R. and Rosenberg, R. D. (2001) 6-O-Sulfotransferase-1 represents a critical enzyme in the anticoagulant heparan sulfate biosynthetic pathway. J. Biol. Chem., 276, 42311-42321.
110. Wu, Z. L., Zhang, L., Yabe, T., Kuberan, B., Beeler, D. L., Love, A. and Rosenberg, R. D. (2003) The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex. J. Biol. Chem., 278, 17121-17129.
111. Nishimura, Y., Satoh, T., Kondo, S., Takeuchi, T., Azetaka, M., Fukuyasu, H., Iizuka, Y. and Shibahara, S. (1994) Effect on spontaneous metastasis of mouse Lewis lung carcinoma by a trifluoroacetamide analogue of siastatin B. J. Antibiot., 47. 840-842.
112. Niwa, T., Tsuruoka, T., Inouye, S., Naito, Y., Koeda, T. and Niida, T. (1972) A new potent α-glucuronidase inhibitor, d-glucaro--lactam derived from nojirimycin. J. Biochem., 72, 207-211.
113. Tsuruoka, T., Fukuyasu, H., Azetaka, M., Iizuka, Y., Inouye, S., Hosokawa, M. and Kobayashi, H. (1995) Inhibition of pulmonary metastasis and tumor cell invasion in experimental tumors by sodium d-glucaro--lactam (ND2001). Jpn. J. Cancer Res., 86, 41-47.
114. Kuramitsu, Y., Hamada, J-I., Tsuruoka, T., Morikawa, K., Kobayashi, H. and Hosokawa, M. (1998) A new anti-metastatic drug, ND-2001, inhibits lung metastases in rat hepatoma cells by suppressing haptotaxis of tumor cells toward laminin. Ant-Cancer Drugs, 9, 88-92.